Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00891163 · ClinicalTrials.gov registry record · Phase 4
Evaluate the Depth and Duration of Anesthesia
A Phase 4 study, sponsored by ZARS Pharma.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT00891163 is a Phase 4 study that has completed, run by ZARS Pharma. The registered enrollment target is 25 participants.
The verdict
NCT00891163, a Phase 4 study, has completed, sponsored by ZARS Pharma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the depth (mm) of anesthesia provided by the Synera topical patch (using sensory depth and pain depth evaluations), and to determine the duration (minutes) of anesthesia provided by the Synera topical patch (using dermal sensory testing and thermal sensory testing evaluations), compared with a matching heated placebo patch.
Interventions
- DRUG Placebo Patch
- DRUG Synera™ Topical Patch (70 mg lidocaine/70 mg tetracaine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-12 |
| Est. Completion | 2007-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00891163
The ClinicalTrials.gov registry entry for NCT00891163 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ZARS Pharma, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Patch is the first listed.
NCT00891163 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00891163 about?
NCT00891163 is a clinical study titled "Evaluate the Depth and Duration of Anesthesia". The purpose of the study is to determine the depth (mm) of anesthesia provided by the Synera topical patch (using sensory depth and pain depth evaluations), and to determine the duration (minutes) of anesthesia provided by the Synera topical patch (using dermal sensory testing and thermal sensory te...
What is the current status of trial NCT00891163?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2006-12. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00891163?
The interventions under investigation include: Placebo Patch (DRUG), Synera™ Topical Patch (70 mg lidocaine/70 mg tetracaine) (DRUG).
Who is sponsoring clinical trial NCT00891163?
This trial is sponsored by ZARS Pharma, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.